We appreciate the opportunity to address the questions raised by Moran et al regarding our recent analysis of prespecified secondary sleep outcomes from a four-arm randomized controlled trial of electro-acupuncture (EA), sham acupuncture, gabapentin (GP), or placebo in breast cancer survivors with persistent hot flashes.1 The results of the primary outcome, hot flashes, has been previously published and was referred to in the “Methods” section to provide the reader with the broader context of the study. As stated in the article, our intention was to compare the effectiveness of the two active treatment arms (EA and GP) to estimate the related effects of EA to an established pharmacological intervention on sleep quality in women who experience hot flashes.2
The main concern of the commentators was regarding a discrepancy between the design reported and the ClinicalTrials.gov Identifier number. We are grateful to the commentators for identifying this typographical error, a mistake on our part, which likely contributed to the bulk of their confusion. The appropriate identifier number is ClinicalTrials.gov Identifier: NCT01005108. We will work with the publisher to correct this error and prevent any further confusion.